Logo image of FRE.DE

FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis

Europe - FRA:FRE - DE0005785604 - Common Stock

47.64 EUR
-0.61 (-1.26%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to FRE. FRE was compared to 27 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FRE get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, FRE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year FRE was profitable.
FRE had a positive operating cash flow in the past year.
Of the past 5 years FRE 4 years were profitable.
FRE had a positive operating cash flow in each of the past 5 years.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

FRE's Return On Assets of 2.72% is in line compared to the rest of the industry. FRE outperforms 59.26% of its industry peers.
FRE has a Return On Equity (6.15%) which is in line with its industry peers.
FRE has a worse Return On Invested Capital (3.29%) than 62.96% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FRE is below the industry average of 6.04%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(3.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.72%
ROE 6.15%
ROIC 3.29%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

FRE has a better Profit Margin (5.06%) than 85.19% of its industry peers.
In the last couple of years the Profit Margin of FRE has declined.
FRE has a better Operating Margin (9.96%) than 85.19% of its industry peers.
FRE's Operating Margin has declined in the last couple of years.
FRE has a Gross Margin (25.40%) which is in line with its industry peers.
In the last couple of years the Gross Margin of FRE has declined.
Industry RankSector Rank
OM 9.96%
PM (TTM) 5.06%
GM 25.4%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
FRE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, FRE has an improved debt to assets ratio.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

FRE has an Altman-Z score of 2.12. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of FRE (2.12) is comparable to the rest of the industry.
The Debt to FCF ratio of FRE is 10.07, which is on the high side as it means it would take FRE, 10.07 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.07, FRE is in line with its industry, outperforming 44.44% of the companies in the same industry.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
FRE's Debt to Equity ratio of 0.61 is fine compared to the rest of the industry. FRE outperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 10.07
Altman-Z 2.12
ROIC/WACC0.63
WACC5.25%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

FRE has a Current Ratio of 1.31. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of FRE (1.31) is better than 66.67% of its industry peers.
FRE has a Quick Ratio of 1.31. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
FRE's Quick ratio of 1.00 is in line compared to the rest of the industry. FRE outperforms 59.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 157.43%, which is quite impressive.
Measured over the past years, FRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.29% on average per year.
Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 3.64% in the last year.
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)157.43%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%-70.97%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%4.05%

3.2 Future

FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.89% yearly.
FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.79% yearly.
EPS Next Y13.47%
EPS Next 2Y11.01%
EPS Next 3Y10.1%
EPS Next 5Y9.89%
Revenue Next Year4.78%
Revenue Next 2Y4.9%
Revenue Next 3Y4.87%
Revenue Next 5Y4.79%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.14, which indicates a rather expensive current valuation of FRE.
Compared to the rest of the industry, the Price/Earnings ratio of FRE is on the same level as its industry peers.
When comparing the Price/Earnings ratio of FRE to the average of the S&P500 Index (25.83), we can say FRE is valued slightly cheaper.
The Price/Forward Earnings ratio is 12.84, which indicates a correct valuation of FRE.
The rest of the industry has a similar Price/Forward Earnings ratio as FRE.
FRE is valuated cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.14
Fwd PE 12.84
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as FRE.
70.37% of the companies in the same industry are cheaper than FRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.05
EV/EBITDA 10.55
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.27
PEG (5Y)N/A
EPS Next 2Y11.01%
EPS Next 3Y10.1%

3

5. Dividend

5.1 Amount

FRE has a Yearly Dividend Yield of 1.99%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.55, FRE pays a bit more dividend than its industry peers.
FRE's Dividend Yield is comparable with the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2015 2016 2019 2020 2021 2022 2023 2025 0.5 1 1.5

5.3 Sustainability

FRE pays out 58.31% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.31%
EPS Next 2Y11.01%
EPS Next 3Y10.1%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS SE & CO KGAA

FRA:FRE (11/7/2025, 7:00:00 PM)

47.64

-0.61 (-1.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners44.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.83B
Revenue(TTM)21.83B
Net Income(TTM)1.13B
Analysts85.22
Price Target52.28 (9.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP58.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.26%
Min EPS beat(2)8.91%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.92%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.85%
EPS beat(12)6
Avg EPS beat(12)-41.15%
EPS beat(16)8
Avg EPS beat(16)-31.82%
Revenue beat(2)2
Avg Revenue beat(2)2.07%
Min Revenue beat(2)1.31%
Max Revenue beat(2)2.84%
Revenue beat(4)4
Avg Revenue beat(4)1.74%
Min Revenue beat(4)0.41%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.11%
Revenue beat(16)6
Avg Revenue beat(16)0%
PT rev (1m)2.69%
PT rev (3m)5.67%
EPS NQ rev (1m)0.22%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.07%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 17.14
Fwd PE 12.84
P/S 1.21
P/FCF 21.05
P/OCF 11.93
P/B 1.47
P/tB 18.45
EV/EBITDA 10.55
EPS(TTM)2.78
EY5.84%
EPS(NY)3.71
Fwd EY7.79%
FCF(TTM)2.26
FCFY4.75%
OCF(TTM)3.99
OCFY8.38%
SpS39.46
BVpS32.46
TBVpS2.58
PEG (NY)1.27
PEG (5Y)N/A
Graham Number45.06
Profitability
Industry RankSector Rank
ROA 2.72%
ROE 6.15%
ROCE 6.7%
ROIC 3.29%
ROICexc 3.6%
ROICexgc 7.96%
OM 9.96%
PM (TTM) 5.06%
GM 25.4%
FCFM 5.74%
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 10.07
Debt/EBITDA 3.32
Cap/Depr 86.89%
Cap/Sales 4.38%
Interest Coverage 6.1
Cash Conversion 67.46%
Profit Quality 113.33%
Current Ratio 1.31
Quick Ratio 1
Altman-Z 2.12
F-Score8
WACC5.25%
ROIC/WACC0.63
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.43%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%-70.97%
EPS Next Y13.47%
EPS Next 2Y11.01%
EPS Next 3Y10.1%
EPS Next 5Y9.89%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%4.05%
Revenue Next Year4.78%
Revenue Next 2Y4.9%
Revenue Next 3Y4.87%
Revenue Next 5Y4.79%
EBIT growth 1Y69.58%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year66.43%
EBIT Next 3Y24.05%
EBIT Next 5Y15.46%
FCF growth 1Y-50.31%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-49.36%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%

FRESENIUS SE & CO KGAA / FRE.DE FAQ

What is the ChartMill fundamental rating of FRESENIUS SE & CO KGAA (FRE.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.


What is the valuation status of FRESENIUS SE & CO KGAA (FRE.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Overvalued.


Can you provide the profitability details for FRESENIUS SE & CO KGAA?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for FRE stock?

The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10.


Can you provide the dividend sustainability for FRE stock?

The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 58.31%.